Investing.com -- Sodexo (EPA: EXHO) faced renewed pressure as Barclays and HSBC downgraded the stock, raising concerns over ...

UBS has initiated coverage of BSE with a 'buy' rating, highlighting diverse revenue streams and potential margin improvement.

Goldman Sachs plans to trim its staffing by 3% to 5% in an annual performance review process this spring, said a source familiar with the matter who declined to be identified discussing personnel ...

Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.

The most recent trading session ended with Goldman Sachs (GS) standing at $559.67, reflecting a -1.41% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which ...

NEW YORK (Reuters) -Goldman Sachs plans to trim its staffing by 3% ... in 2023 as dealmaking stagnated and it stepped back from a loss-making consumer business. The environment for banks has ...

NEW YORK (Reuters) -Goldman Sachs plans to trim its staffing by 3% to 5% in an annual ... workforce reductions in 2023 as dealmaking stagnated and it stepped back from a loss-making consumer business.

Goldman Sachs highlighted that National Stock Exchange ... weighed down by concerns over a potential market share loss in the options segment. The stock’s downturn followed NSE’s confirmation ...

CoreWeave's stock fell as much as 5% in the first hours of trading on Friday before rebounding to near their $40 IPO price.

Wall Street investment banking major Goldman Sachs sees downside risks to its average Brent crude oil futures forecasts for 2025 and 2026 in the wake of OPEC+’s plans to increase oil output in ...